「Evaluation of Time to Failure of Strategy as an Alternative Surrogate Endpoint in Lung Cancer Patients with EGFR Mutations.」の関連論文
-
Clinical efficacy of osimertinib in EGFR-mutant non-small cell lung cancer with distant metastasis
-
膠芽腫におけるPIK3CA遺伝子変異の臨床的意義についての考察
-
The survival benefit of neoadjuvant chemotherapy for resectable colorectal liver metastases with high tumor burden score
-
Non-invasive early prediction of immune checkpoint inhibitor efficacy in non-small-cell lung cancer patients using on-treatment serum CRP and NLR
-
免疫チェックポイント阻害薬使用患者の癌種横断的レジストリの構築、ならびに治療効果・免疫関連有害事象発現の予測に関する研究
-
<学会抄録>第70回日本泌尿器科学会中部総会
-
Clinical Implications of Pre- and Postoperative Circulating Tumor DNA in Patients with Resected Pancreatic Ductal Adenocarcinoma
-
Clinical Implications of Pre- and Postoperative Circulating Tumor DNA in Patients with Resected Pancreatic Ductal Adenocarcinoma
-
膵癌における新規S-1感受性予測因子のプロテオミクスによる網羅的探索
-
Phase 2 Trial of Adjuvant Chemotherapy With S - 1 for Node-Positive Biliary Tract Cancer (N-SOG 09)
-
A multicenter, open‑label, single‑arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer
-
Low ETV1 mRNA expression is associated with recurrence in gastrointestinal stromal tumors
-
Efficacy and Safety of Sorafenib in Unresectable Hepatocellular Carcinoma with Bile Duct Invasion
-
ニボルマブによる治療を行った転移性腎細胞癌患者における血清中可溶性PD-L1の予後予測効果
-
転移または再発乳癌の末梢血循環DNA変異解析の検討
-
Extracellular miRNAs as Predictive Biomarkers for Glypican-3-Derived Peptide Vaccine Therapy Response in Ovarian Clear Cell Carcinoma
-
EGFR-TKI耐性と腫瘍内組織免疫微小環境との相互作用についての検討
-
食道癌の根治的放射線治療における骨格筋のラジオミクス解析の予後的意義
-
リキッドバイオプシーを用いた局所進行直腸癌術前治療症例の治療効果予測に関する研究
-
がん終末期患者の余命予測マーカーの探索と薬学部生における一般名と商品名による医薬品理解度に及ぼす実務実習の影響に関する研究
-
日本人クローン病における適切な治療戦略の構築に関する後方視的および前向き研究 ~日本人クローン病のTreat-to-Target戦略におけるバイオマーカーの有用性と至適基準の検討~
-
癌患者ゲノミクスデータ解析を基盤とした乳癌幹細胞性維持機構の解明
-
Clinical significance of serglycin expression in human breast cancer patients
-
Eosinophil prognostic scores for patients with head and neck squamous cell carcinoma treated with nivolumab
-
新規治療薬登場後における日本人潰瘍性大腸炎患者の長期経過の解析
-
Neoadjuvant CAPOX and bevacizumab alone for locally advanced rectal cancer: long-term results from the N-SOG 03 trial
-
Long-Term Prognostic Predictors of Esophageal Squamous Cell Carcinoma Potentially Indicated for Endoscopic Submucosal Dissection
-
Clustering using unsupervised machine learning to stratify the risk of immune-related liver injury
-
The pathological complete response and secreted protein acidic and rich in cysteine expression in patients with breast cancer receiving neoadjuvant nab-paclitaxel chemotherapy
-
Novel Prognostic Implications of DUPAN-2 in the Era of Initial Systemic Therapy for Pancreatic Cancer
-
術前化学療法を施行した食道扁平上皮癌におけるGlucocorticoid(GC)-Glucocorticoid receptor(GR)伝達経路関連因子の臨床病理学的,免疫組織学的検討
-
Single-center prognostic validation of the risk assessment of the 2015 ESC/ERS guidelines in patients with pulmonary arterial hypertension in Japan
-
癌幹細胞マーカーが、食道扁平上皮癌における術前化学療法の抵抗性を予測する
-
Clinical significance of topoisomerase-II expression in patients with advanced Non-Small Cell Lung Cancer treated with amrubicin
-
肝芽腫におけるDNA メチル化解析に基づく新規リスク層別化モデルの検討
-
Immunohistological evaluation of mismatch repair deficiency in pancreatic ductal adenocarcinoma treated with surgical resection
-
Immunohistological evaluation of mismatch repair deficiency in pancreatic ductal adenocarcinoma treated with surgical resection
-
低腫瘍量濾胞性リンパ腫における遺伝子発現に基づく新規予後予測モデルの構築
-
リアルワールドデータ解析に基づく抗TNF-α抗体医薬品の適正使用に関する研究
-
日本の高齢者肺癌に対する初回治療についてのレジストリデータを用いた解析
-
肺腫瘍に対する体幹部定位照射(SBRT)に関する治療戦略
-
Multicenter Prospective Study of the Efficacy and Safety of Combined Immunosuppressive Therapy With High-Dose Glucocorticoid, Tacrolimus, and Cyclophosphamide in Interstitial Lung Diseases Accompanied by Anti-Melanoma Differentiation-Associated Gene 5-Positive Dermatomyositis
-
Optimized radiotherapy treatment strategy for early glottic carcinoma
-
Comparing incidences of infusion site reactions between brand-name and generic vinorelbine in patients with non-small cell lung cancer
-
Phase II study of nab-paclitaxel plus cyclophosphamide plus trastuzumab neoadjuvant chemotherapy in early HER-2-positive breast cancer
-
Biological and conditional factors should be included when defining criteria for resectability for patients with pancreatic cancer
-
The ISN/RPS 2016 classification predicts renal prognosis in patients with first-onset class III/IV lupus nephritis
-
成人IgA腎症の長期予後に関する検討:可能な限りの追跡調査を実施した単施設コホートによる検討
-
二相撮像FDG-PETを用いた中咽頭癌患者におけるp16発現の関連性および予後予測に関する検討
-
Robustness of Clonogenic Assays as a Biomarker for Cancer Cell Radiosensitivity.